全文获取类型
收费全文 | 1476篇 |
免费 | 99篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 47篇 |
妇产科学 | 20篇 |
基础医学 | 147篇 |
口腔科学 | 55篇 |
临床医学 | 212篇 |
内科学 | 324篇 |
皮肤病学 | 7篇 |
神经病学 | 78篇 |
特种医学 | 179篇 |
外科学 | 150篇 |
综合类 | 32篇 |
预防医学 | 115篇 |
眼科学 | 14篇 |
药学 | 129篇 |
肿瘤学 | 79篇 |
出版年
2023年 | 16篇 |
2022年 | 15篇 |
2021年 | 34篇 |
2020年 | 18篇 |
2019年 | 23篇 |
2018年 | 24篇 |
2017年 | 17篇 |
2016年 | 25篇 |
2015年 | 17篇 |
2014年 | 29篇 |
2013年 | 46篇 |
2012年 | 46篇 |
2011年 | 47篇 |
2010年 | 38篇 |
2009年 | 59篇 |
2008年 | 68篇 |
2007年 | 70篇 |
2006年 | 46篇 |
2005年 | 49篇 |
2004年 | 40篇 |
2003年 | 52篇 |
2002年 | 48篇 |
2001年 | 44篇 |
2000年 | 41篇 |
1999年 | 31篇 |
1998年 | 50篇 |
1997年 | 43篇 |
1996年 | 53篇 |
1995年 | 40篇 |
1994年 | 32篇 |
1993年 | 33篇 |
1992年 | 21篇 |
1991年 | 17篇 |
1990年 | 16篇 |
1989年 | 37篇 |
1988年 | 41篇 |
1987年 | 27篇 |
1986年 | 19篇 |
1985年 | 31篇 |
1984年 | 21篇 |
1983年 | 16篇 |
1982年 | 24篇 |
1981年 | 13篇 |
1980年 | 18篇 |
1979年 | 12篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1976年 | 11篇 |
1973年 | 8篇 |
1972年 | 10篇 |
排序方式: 共有1595条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Frederic Grabowski Grzegorz Preibisch Stanisaw Giziski Marek Kochaczyk Tomasz Lipniacki 《Viruses》2021,13(3)
The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England. The VOC has been detected in 40 out of 46 countries that reported at least 50 genomes in January 2021. We have estimated that the replicative advantage of the VOC is in the range 1.83–2.18 [95% CI: 1.71–2.40] with respect to the 20A.EU1 variant that dominated in England in November 2020, and in range 1.65–1.72 [95% CI: 1.46–2.04] in Wales, Scotland, Denmark, and USA. As the VOC strain will likely spread globally towards fixation, it is important to monitor its molecular evolution. We have estimated growth rates of expanding mutations acquired by the VOC lineage to find that the L18F substitution in spike has initiated a fast growing VOC substrain. The L18F substitution is of significance because it has been found to compromise binding of neutralizing antibodies. Of concern are immune escape mutations acquired by the VOC: E484K, F490S, S494P (in the receptor binding motif of spike) and Q677H, Q675H (in the proximity of the polybasic cleavage site at the S1/S2 boundary). These mutants may hinder efficiency of existing vaccines and expand in response to the increasing after-infection or vaccine-induced seroprevalence. 相似文献
55.
56.
Amanda Hill Paula Gibbs Kimberly Reed Ann Hanshaw Ruthie Rivera Keisha Franks Marquita Justice Terri Moore Jessica Alger Amy Daniel Anil Adiga Dr. Mark Diehl Matthew Grabowski Margaret Holtz Janie Mixon Stephen Kim Stanley Dysart Vanessa Ellington Ashley Prettyman 《Journal of PeriAnesthesia Nursing》2019,34(4):e20-e21
57.
Ronith Elk Robert Andres Andrew Helfgott Howard Rhoades Lorna Mangus Iman Mirza Ramona Burroughs John Grabowski 《The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions》1996,5(4):292-300
The authors investigated AIDS-related knowledge, high-risk behaviors, and relationships between AIDS-related knowledge, high-risk behaviors, and sociodemographic characteristics of 41 pregnant women entering treatment who were dependent on cocaine or opiates. At entry, patients completed self-report questionnaires on AIDS-related knowledge and sexual and drug use practices. There was a high rate of understanding of risk associated with drug use and perinatal transmission of HIV. Knowledge of high-risk sexual behavior varied, and knowledge of the medical consequences of HIV was modest. Engagement in several high-risk behaviors was identified: lack of condom use, intravenous drug use, sharing of needles, sex with an injecting drug user, and exchanging sex for money or drugs. AIDS-related knowledge and engagement in high-risk behaviors were not significantly correlated. Authors discussed implications of these findings for developing effective HIV prevention strategies in this population. (American Journal on Addictions 1996; 5:292–300) 相似文献
58.
de Koning JP; Dong F; Smith L; Schelen AM; Barge RM; van der Plas DC; Hoefsloot LH; Lowenberg B; Touw IP 《Blood》1996,87(4):1335-1342
59.
Prevalence of type 1 Gaucher disease in the United States 总被引:1,自引:0,他引:1
Weinreb NJ Andersson HC Banikazemi M Barranger J Beutler E Charrow J Grabowski GA Hollak CE Kaplan P Mankin H Mistry PK Rosenbloom BE Vom Dahl S Zimran A 《Archives of internal medicine》2008,168(3):326-7; author reply 327-8
60.
The balance of tissue-type plasminogen activator (t-PA) production and degradation determines its concentration in blood and tissues. Disturbance of this balance may result in either increased or decreased proteolysis. In the present study, we identified the receptor systems involved in the degradation of t-PA by human monocytes/macrophages in culture. Monocytes were cultured and became macrophages within 2 days. At 4 degrees C, 125I-t-PA bound to macrophages with high (apparent dissociation constant [kd], 1 to 5 nmol/L) and low affinity (kd > 350 nmol/L). At 37 degrees C, the cells internalized and degraded t-PA via the high affinity binding sites, which were partially inhibited by mannan. The low affinity binding sites were 6-aminohexanoic acid- inhibitable and not involved in t-PA degradation. Degradation of t-PA was upregulated during differentiation of monocytes to macrophages. Dexamethasone further upregulated the mannan-inhibitable t-PA degradation. Lipopolysaccharide downregulated both mannan-inhibitable and non-mannan-inhibitable t-PA degradation. Non-mannan-inhibitable degradation was completely blocked by recombinant 39-kD receptor- associated protein (RAP, inhibitor of lipoprotein receptor-related protein [LRP]), whereas mannan-inhibitable degradation was blocked by the addition of a monoclonal antibody against the mannose receptor. No differences between the degradation of t-PA and functionally inactivated t-PA were observed. We conclude that human monocyte-derived macrophages are able to bind, internalize, and degrade t-PA. Degradation of t-PA does not require complex formation with plasminogen activator inhibitors. The macrophages use two independently regulated receptors, namely, the mannose receptor and LRP, for the uptake and degradation of t-PA. 相似文献